Ruth O’Regan

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA

Mary Jo Lund, Katrina F. Trivers, Peggy L. Porter et al. · Breast Cancer Research and Treatment · 2008 · 395 citations

Epidemiology, Population-based Study, Cancer Epidemiology +15

Quantum Dots for Human Mesenchymal Stem Cells Labeling. A Size-Dependent Autophagy Activation

Oleksandr Seleverstov, Olga Zabirnyk, Matthias Zscharnack et al. · Nano Letters · 2006 · 243 citations

Engineering, Adult Stem Cell, Nanotoxicology +19

A randomized, phase II trial of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibition (CDK 4/6i) in patients (pts) with unresectable or hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC): MAINTAIN trial.

Kevin Kalinsky, Melissa Accordino, Codruța Chiuzan et al. · Journal of Clinical Oncology · 2022 · 73 citations

Breast Oncology, Cancer Management, Pharmacotherapy +18

Inorganic Nanoparticles for Predictive Oncology of Breast Cancer

Maksym Yezhelyev, Rami Yacoub, Ruth O’Regan · Nanomedicine · 2008 · 45 citations

Nanoparticles, Nanomedicine, Engineering +14

Silencing CDK4 radiosensitizes breast cancer cells by promoting apoptosis

Katie R. Hagen, Xiangbin Zeng, Mi‐Young Lee et al. · Cell Division · 2013 · 40 citations · Full text